EMEA-001204-PIP02-14
Key facts
Active substance |
|
Therapeutic area |
Cardiovascular diseases
|
Decision number |
P/0079/2015
|
PIP number |
EMEA-001204-PIP02-14
|
Pharmaceutical form(s) |
Film-coated tablet
|
Condition(s) / indication(s) |
Prevention of coronary artery disease
|
Route(s) of administration |
Oral use
|
Contact for public enquiries |
Merck Sharp & Dohme Ltd
|
Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|